There is a great post on QFT blog about how much Oxford Immunotech has spent getting Tspot to market
http://quantiferon.blogspot.com/
by way of comparison... CST raised about $A20 million over the years, and now sits with $A20 million in the bank as it mvoes forward as a profitable company.
Comapre that with OI battling to get Tspot to market